An open-label, randomized, single dose, two period, crossover study to determine the bioavailability of valsartan oral solution formulation relative to the valsartan tablet formulation [Diovan; Novartis] in healthy adult subjects.
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2016
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Pharmacogenomic; Pharmacokinetics
- Sponsors Novartis
- 04 Jan 2011 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India record.
- 13 Sep 2010 New trial record